Doctor profile · Federal record
Dr. RAJASEKARAN ANNAMALAI, MD
Internal Medicine Physician (CMS: INTERNAL MEDICINE) · TOMBALL, TX
- NPI 1932210234
- Accepts Medicare
- 28 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
11011 NORTHPOINTE BLVD STE C
TOMBALL, TX 773751572
(281) 246-1100
fax (281) 430-1100
Credentials & registration
- NPI registered
- August 2006 — 20 yrs on file
- Profile last updated
- April 10, 2024
- Year of graduation
- 1998 — 28 yrs since
- Specialty taxonomy
- 207R00000X — NUCC code
- State license (1)
- Texas #N0611
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1932210234. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
639
Distinct HCPCS
10
Medicare allowed
$44,640
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 189 | 60 | $129 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 130 | 58 | $88 | |
J0696 |
Injection, ceftriaxone sodium, per 250 mg | 68 | 12 | $0 | |
87804 |
Detection test by immunoassay with direct visual observation for influenza virus | 50 | 21 | $16 | |
96372 |
Injection of drug or substance under skin or into muscle | 40 | 26 | $14 | |
G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 39 | 39 | $130 | |
87426 |
Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 26 | 21 | $35 | |
87880 |
Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 22 | 18 | $16 | |
36415 |
Insertion of needle into vein for collection of blood sample | 21 | 20 | $8 | |
81002 |
Urinalysis, manual test | 20 | 16 | $3 |
In context: peer comparison
Among 8 peers in this city , average services per provider: 280. This provider delivers 2.3× the peer median.Open Payments
Industry payments received
All-time total
$476
Transactions
18
Manufacturers
10
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Phathom Pharmaceuticals, Inc. | 2 | $148.88 | |
| Amgen Inc. | 4 | $81.35 | |
| IRONSHORE PHARMACEUTICALS INC. | 3 | $72.61 | |
| PFIZER INC. | 2 | $42.04 | |
| Verrica Pharmaceuticals Inc. | 2 | $37.32 | |
| Phadia US Inc. | 1 | $24.38 | |
| Novartis Pharmaceuticals Corporation | 1 | $22.16 | |
| Abbott Laboratories | 1 | $15.99 | |
| Otsuka America Pharmaceutical, Inc. | 1 | $15.74 | |
| AstraZeneca Pharmaceuticals LP | 1 | $15.58 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,747
Patients
571
Total drug cost
$30,329
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Atorvastatin Calcium | Generic | 234 | 71 | $4,600 |
| Levothyroxine Sodium | Generic | 225 | 47 | $3,452 |
| Montelukast Sodium | Generic | 150 | 57 | $2,451 |
| Gabapentin | Generic | 133 | 41 | $2,735 |
| Rosuvastatin Calcium | Generic | 117 | 35 | $2,643 |
| Metformin Hcl | Generic | 106 | 32 | $1,265 |
| Pantoprazole Sodium | Generic | 102 | 37 | $1,709 |
| Olmesartan Medoxomil | Generic | 99 | 29 | $3,031 |
| Tizanidine Hcl | Generic | 97 | 46 | $849 |
| Tramadol Hcl | Generic | 95 | 27 | $645 |